Clinical Trials on HIV Primary Infection in France

Total 10383 results

Assistance Publique - Hôpitaux de Paris
Gilead Sciences

Terminated

HCV, HBV, HIV Testing During Consultation With Anesthesiologist (SAHARA)

Hiv | HBV | HCV

France
ANRS, Emerging Infectious Diseases
Bristol-Myers Squibb

Completed

Pilot Study to Assess the Efficacy of and Tolerance to a QUadruple Therapy to Treat HIV-HCV Coinfected Patients Previously Null Responders (QUADRIH)

HCV-HIV Co-Infection

France
ANRS, Emerging Infectious Diseases
Merck Sharp & Dohme LLC; Rennes University Hospital

Completed

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin (BocepreVIH)

HIV-1 Infection | HCV Coinfection

France
University Hospital, Rouen
Hoffmann-La Roche

Terminated

Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules (AMPHORE)

HIV Infections | HIV1 Infection

France
French National Agency for Research on AIDS and...

Completed

Accelerated Aging, HIV Infection, Antiretroviral Therapies (EP 45)

HIV Infection | Aging Accelerated | Antiretroviral Therapies

France
ANRS, Emerging Infectious Diseases

Completed

Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection

HIV | Viral Hepatitis C

France
ANRS, Emerging Infectious Diseases
Merck Sharp & Dohme LLC; Pfizer; Gilead Sciences; Janssen-Cilag Ltd.

Completed

Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)

HIV-1 Infections

France
Assistance Publique Hopitaux De Marseille

Unknown

Analysis of the Impact of HCV Treatment by Last Generation Direct Antiviral Agents (DAA) on Antiviral Immunity and HIV DNA Reservoir in Coinfected HIV-HCV Patients (HCURE)

HIV Associated HCV

France
ANRS, Emerging Infectious Diseases

Terminated

Cohort Study of Volunteers That Have Participated to Preventive HIV-1 Vaccine Trials

HIV Infection | HIV Seronegativity

France
Assistance Publique - Hôpitaux de Paris
INSERM CESP1018

Completed

Sexual Needs of Adolescents Living With HIV Since Childhood (SSVIH)

Hiv | Perinatal HIV Infection

France
ANRS, Emerging Infectious Diseases

Completed

Physiopathology Study of the Microbiota Biodiversity of HIV Seropositive Patients (MICROGUT)

HIV-1 Infection

France
French National Agency for Research on AIDS and...

Completed

Cohort of Young Adults Infected With HIV Since Birth or During Childhood (CO19 COVERTE)

HIV Infection | Young Adult

France
Hopital Lariboisière

Completed

Antiretroviral Therapy and Extreme Weight (EXTATIC)

HIV Infection

France
University Hospital, Strasbourg, France

Unknown

Genotyping FcɣRs Genes of HIV-1 Patients "Progressor": Correlation With the Changing Profile of the Infection

HIV Infection

France
Centre de Recherches et d'Etude sur la Pathologie...

Completed

Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection. (RADAR)

HIV Infections | HIV-1 Infection

France
Centre Hospitalier de Cayenne

Recruiting

Precariousness and Sexual Vulnerability of People From Haiti Living With or Without HIV in French Guiana (ParcoursHaiti)

HIV Seropositivity

French Guiana
ANRS, Emerging Infectious Diseases

Completed

Immunogenicity and Safety of 4 Prime-boost Combinations of HIV Vaccine Candidates in Healthy Volunteers (VRI01)

HIV Infection

France
Centre Hospitalier Universitaire de Besancon

Completed

Exploratory Study of Cellular Reservoirs in Blood From HIV Infected Patients (EURECA)

HIV Infection

France
ANRS, Emerging Infectious Diseases

Completed

Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients (DARULIGHT)

HIV INFECTION

France
ANRS, Emerging Infectious Diseases

Completed

X-linked Biological Response to HIV Sensing: the ANRS EP 53 Study (X LIBRIS)

Hiv Infection

France
Raincy Montfermeil Hospital Group

Recruiting

Prevention, Access to Rights, Catch-up Vaccination, Treatment of Conditions During Pregnancy and for Children (PARTAGE)

HIV Infection

France
ANRS, Emerging Infectious Diseases

Completed

Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients (ANRS EP 52)

Hiv Infection

France
French National Agency for Research on AIDS and...

Completed

Residual Replication of HIV-1 in the Gut Associated Lymphoid Tissue (GALT) of Patients on Highly Active Antiretroviral Therapy (HAART): the ANRS EP 44 Study (EP 44)

HIV Infection

France
University Hospital, Strasbourg, France

Unknown

First Event of Infection by HIV-1 of Uterine Vaginal Tissue

HIV Infection of the Uterine Vaginal Tissues

France
Centre Hospitalier Universitaire Dijon

Completed

Optimization of HIV-1 DNA Genotyping by High Throughput Sequencing to Document Antiretroviral Resistant Mutations (Mutapro)

HIV-1-infection

France
Centre Hospitalier Universitaire de Nīmes
Institut de Génétique Moléculaire de Montpellier

Recruiting

Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment (RESERVIH32)

HIV-1-infection

France
ANRS, Emerging Infectious Diseases

Completed

Cohort of Patients Naive of Antiretroviral Treatment at Enrollment (COPANA)

HIV Infection

France
French National Agency for Research on AIDS and...

Completed

Residual Risk Assessment Of HIV Transmission (EP 49 EVARIST)

HIV Infection

France
French National Agency for Research on AIDS and...

Completed

Patients Infected With HIV Since More Than 10 Years With a Plasma Viral RNA <400 Copies / mL in the Absence of Any Treatment: Study Mechanisms Involved in Controlling the Infection (ANRS CO18)

HIV Infection

France
MagIA Diagnostics

Recruiting

Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned screENing of HIV, Hepatitis B and Hepatitis C (MAGICIEN)

Combined Point of Care Diagnostic of HIV, HBV and HCV

France
French National Agency for Research on AIDS and...
Pfizer

Completed

Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration (145 MARIMUNO)

HIV Infections | HIV Infection

France
ANRS, Emerging Infectious Diseases

Recruiting

the ANRS CO21 " Extreme " Cohort (CODEX) (CODEX)

HIV Infection

France
University Hospital, Montpellier
Institute of Human Genetics, France

Completed

Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy (RALNOVO)

HIV-1 Infection

France
Gérond'if

Recruiting

Medico-social Description of Seniors Living With HIV, Associated With a Qualitative Survey on Their Care in the Paris Region Structures (VIAGE)

HIV-positive

France
Assistance Publique Hopitaux De Marseille

Unknown

Role of the Balano-preputial Furrow 's Microbiota, in Circumcised Patients or Not, in the Acquisition or Transmission of HIV

HIV Infection

France
ANRS, Emerging Infectious Diseases

Completed

Viral Biofilms: Hijacking T Cell Extracellular Matrix to Regulate HIV-1 Spread? (TRANSBioHIV)

HIV Infection

France
Centre Hospitalier Universitaire de Nice

Unknown

Impact of Raltegravir on the Viral Reservoirs

HIV Infection

France
Florida International University

Completed

Growing Up: Intervening With HIV-Positive Adolescents in Resource-Poor Settings

HIV Infection

Haiti
ANRS, Emerging Infectious Diseases
MSD France

Not yet recruiting

DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection (ELDORADO)

HIV-1-infection

Brazil, Cambodia, Cameroon, Côte D'Ivoire, France, Mozambique
Hendrik Streeck
Janssen, LP

Completed

Prospective Observational Cohort HIV & STI Study in Europe

HIV Infections | Sexual Behavior | HIV-1-infection | Risk Reduction

France, Hungary, Spain, Poland, Italy
Assistance Publique - Hôpitaux de Paris
GlaxoSmithKline; Ensemble contre le SIDA

Completed

Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected Patients (HEPAVAC)

HIV Infection

France
Institut de Médecine et d'Epidémiologie Appliquée...
Sidaction

Unknown

Rosuvastatin to Decrease Residual Immune Activation in HIV Infection (CESAR)

HIV-1 Infection

France
University Hospital Center of Martinique
Clinique Antilles-Guyane; Fondation de France

Completed

Epidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana. (HP2V-AG)

1- Women | 2- HIV Infection | 3- Followed in West Indies and French Guiana for His Infection | 4- Acceptance of the Use of Nadis® Medical Files

Martinique
Assistance Publique - Hôpitaux de Paris

Completed

Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy (LIPOPHILL)

HIV Infection | Antiretroviral Side Effects | Lipodystrophy Syndrome Related to HIV Infection

France
University Hospital, Montpellier
Université Montpellier

Terminated

Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women (PAPCLEAR)

Bacterial Vaginosis | HPV Genital Infection (Primary Condition Studied) | Chlamydiae Infection

France
Centre Hospitalier de Cayenne

Completed

Knowledge Attitudes Beliefs and Practices Regarding HIV Among Teenagers in French Guiana (CAPADO)

HIV

France
Centre Hospitalier de Cayenne

Completed

Knowledge Attitudes, Beliefs, and Practices Regarding HIV in Populations Living on the Maroni River (CAPMARONI)

HIV

France
Centre Hospitalier de Cayenne

Completed

Knowledge Attitudes Beliefs and Practices Relative to HIV Among Sex Workers in French Guiana (CAPProstit)

HIV

France
Centre Hospitalier Régional d'Orléans

Recruiting

Study of Autophagy and the Effects of GALIG Gene Products in HIV-1 Infected Patients Who Are Under Antiretroviral Therapy Since Primary-infection, Chronic Phase, or Never Treated. (ATGALIG-HIV)

HIV Infections | Autophagy | Galectins | Highly Active Antiretroviral Therapy

France
ANRS, Emerging Infectious Diseases

Completed

Gut-Associated Lymphocyte Trafficking (GALT)

HIV-1 Infection

France

3

Subscribe